1.
Appl Environ Microbiol
; 72(9): 6402-4, 2006 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16957271
RESUMO
The development of lysine 2,3-aminomutase as a robust biocatalyst hinges on the development of an in vivo activation system to trigger catalysis. This is the first report to show that, in the absence of chemical reductants, lysine 2,3-aminomutase activity is dependent upon the presence of flavodoxin, ferredoxin, or flavodoxin-NADP(+) reductase.